Events |

How can disclosing clinical trial costs increase access to medical products?

A discussion to explore practical implementation of disclosing clinical trial costs: why should this be done and how?

A second roundtable in the series took place on November 17, 2022. At this roundtable, the panellists were asked to focus on some of the more practical aspects of stimulating more transparency around clinical trial costs. During the roundtable, MSF launched its Clinical Trials Transparency Policy with the landmark commitment to publish a minimum set of cost items for the clinical trials it undertakes.

Note: the chat text can be found here.

To find out more about our work on Transparency in Clinical Trial costs, click here.